Am J Transplant, Volume 19, Suppl 3 Archives - Page 41 of 214 - ATC Abstracts

2019 American Transplant Congress
Comparison of Portal vs Systemic Venous Drained Pancreas Transplantation Alone Matched by Propensity Score Analysis
F. Vistoli, N. Napoli, F. Palumbo, E. Kauffmann, V. Perrone, S. Iacopi, C. Lombardo, G. Amorese, P. Marchetti, U. Boggi
Pancreas and Kidney Transplantation Center, University of Pisa, Pisa, Italy
*Purpose: Portal drainage (PD) of pancreas grafts has been associated with improved metabolic profile and fewer rejection episodes than systemic drainage (SD). These advantages would…
2019 American Transplant Congress
Fibrosis Scoring Correlates with Progression of Chronic Pancreatitis, Islet Isolation Yields and Transplant Outcomes in Patients Undergoing Islet Autotransplantation
Y. Liu¹, J. SoRelle², K. Kumano³, S. Vasu³, M. Lawrence⁴, A. Gupta¹, N. Onaca¹, E. Beecherl¹, B. Naziruddin⁴
¹Baylor Simmons Transplant Institute, Dallas, TX, ²UTSouthwestern Medical Center, Dallas, TX, ³Baylor Scott and White Research Institute, Dallas, TX, ⁴Baylor University Medical Ctr, Dallas, TX
*Purpose: Total pancreatectomy with autologous islet transplantation (TPIAT) is a promising procedure for alleviating pain and maintaining glucose homeostasis in chronic pancreatitis (CP) patients. However,…
2019 American Transplant Congress
Correlation between Self-Reported Medication Adherence and Side Effects in Transplant Recipients
T. Harrison¹, K. Foster¹, N. Patel¹, H. Meadows¹, C. Perez¹, H. Corbo¹, J. Fleming¹, N. Pilch¹, D. DuBay², J. McGillicuddy², S. Nadig², V. Rohan², D. Taber¹
¹Pharmacy Services, Medical University of South Carolina, Charleston, SC, ²Transplant Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: Medication non-adherence (MNA) is a major risk factor for acute rejection and graft loss amongst all organ groups. It is unclear how medication side…
2019 American Transplant Congress
Lifelong Immunosuppression, I Am Sure We Told Them That?: Long Term Medication Adherence in Liver Transplant Patients
K. Foster¹, C. Perez¹, T. Harrison¹, H. Corbo¹, N. Patel¹, J. Fleming¹, H. Meadows¹, D. Taber¹, D. DuBay², J. McGillicuddy², N. Pilch¹
¹Department of Pharmacy Services, -Medical University of South Carolina, -Charleston, SC, ²Division of Transplant Surgery, Department of Surgery, -Medical University of South Carolina, -Charleston, SC
*Purpose: Current literature describes demographic information of non-adherent patients and identifies that non-adherence may be predictive of post-txp outcomes. We suspect that patients with private…
2019 American Transplant Congress
Whole Body CT Imaging in Deceased Donor Screening
J. W. Mensink¹, R. A. Pol.², W. N. Nijboer¹, J. de Jonge³, K. M. Ooms - de Vries⁴, M. F. van der Jagt⁵, M. C. van de Poll⁶, I. P. Alwayn¹, A. E. Braat¹
¹Department of Surgery; Division of Transplantation, Leiden University Medical Center, Leiden, Netherlands, ²Department of Surgery; Division of Transplantation, University Medical Center Groningen, Groningen, Netherlands, ³Department of Surgery; Division of Transplantation, Erasmus Medical Center, Rotterdam, Netherlands, ⁴Dutch Transplant Foundation, Leiden, Netherlands, ⁵Department of Surgery; Division of Transplantation, University Medical Center St. Radboud, Nijmegen, Netherlands, ⁶Department of Surgery and Department of Intensive Care, Maastricht University Medical Center, Maastricht, Netherlands
*Purpose: Using older (extended criteria) donors to increase the donor pool increases the risk of malignancies in the donor. Our aim was to analyze the…
2019 American Transplant Congress
Biomarkers in Multivisceral and Intestinal Transplantation
D. A. Cheung¹, J. Garcia¹, T. Beduschi², A. H. Langshaw¹, K. L. Arheart³, I. A. Gonzalez⁴
¹Pediatric Gastroenterology, University of Miami, Miami, FL, ²Surgery, Division of Liver/GI Transplant, University of Miami, Miami, FL, ³Public Health Sciences, Division of Biostatistics, University of Miami, Miami, FL, ⁴Pediatric Infectious Diseases and Immunology, University of Miami, Miami, FL
*Purpose: Multivisceral transplant (MVT) and isolated intestinal transplant (ITx) are complex surgical procedures that result in a pro-inflammatory state, making interpretation of biomarkers in the…
2019 American Transplant Congress
Willingness to Acquire Donor-Derived Hepatitis C Infection May Reduce Waitlist Mortality for Heart Transplant Candidates
B. E. Lonze, A. Reyentovich, N. Moazami, D. E. Smith, C. Gidea, R. A. Montgomery
NYU Langone Transplant Institute, New York, NY
*Purpose: Hearts from deceased donors with hepatitis C infection (HCV+) are disproportionately discarded because most waitlist registrants are HCV negative (HCV-). For some with end-organ…
2019 American Transplant Congress
Pathologic Vascular Invasion Correlates with Worse Outcome in Hepatoblastoma Patients Treated with Liver Transplantation – A Hepatoblastoma Transplant Consortium Study
T. H. Malik¹, H. Zhu², T. Ha³, S. Commander⁴, C. Trautz⁵, R. Sindhi⁵, S. Kim⁶, K. Vakili⁶, N. Vachharajani⁷, W. Chapman⁷, A. Griesemer⁸, M. Martinez⁸, J. A. Goss⁹, S. Vasudevan¹⁰
¹Baylor College of Medicine, Houston, TX, ²Texas Children's Hospital, Houston, TX, ³Department of Surgery, Baylor College of Medicine, Houston, TX, ⁴Department of Surgery, Duke University School of Medicine, Durham, NC, ⁵Department of Surgery, University of Pittsburgh, Pittsburgh, PA, ⁶Department of Surgery, Boston Children's Hospital, Boston, MA, ⁷Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, ⁸Department of Surgery, NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, NY, ⁹Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, ¹⁰Department of Pediatric Surgery, Texas Children's Hospital, Houston, TX
*Purpose: Orthotopic liver transplant (OLTx) is the most common method to treat unresectable hepatoblastoma (HB) in children. There is limited data focusing on the outcomes…
2019 American Transplant Congress
The Important Roles of Dendritic Cells in Transplantation
T. Ueno¹, M. M. McGrath¹, M. Y. Yeung¹, S. Cai¹, Y. Ueno¹, T. Yokoyama², Y. Kihara², O. Konno², Y. Nakamura², H. Iwamoto², A. K. Chandraker¹
¹Medicine, Renal Division, Brigham and Women's Hospital, Transplantation Research Center, Boston, MA, ²Kidney Transplantation Surgery, Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan
*Purpose: The interplay between dendritic cells (DCs) and T cells plays a central role in the process of allograft rejection. Upon antigen exposure, positive costimulatory…
2019 American Transplant Congress
Full and Sustained Donor Hematopoietic Chimerism after an Isolated Kidney Transplantation
J. Zuber¹, O. Boyer¹, B. Neven¹, E. Six², R. Berthaud¹, M. Ould Rabah¹, S. Sobrino², C. Lagresle², I. André-Schmutz², M. Cavazzana¹, S. Blanche¹, R. Salomon¹
¹Paris Descartes University, Paris, France, ²Inserm UMRS 1163, Paris, France
*Purpose: Full donor chimerism was reported three times in the absence of myelosuppressive regimen, only after liver or multivisceral transplantation, but never after kidney transplantation.…